176 related articles for article (PubMed ID: 20332638)
1. Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study.
Degerman Gunnarsson M; Lindau M; Wall A; Blennow K; Darreh-Shori T; Basu S; Nordberg A; Larsson A; Lannfelt L; Basun H; Kilander L
Dement Geriatr Cogn Disord; 2010; 29(3):204-12. PubMed ID: 20332638
[TBL] [Abstract][Full Text] [Related]
2. High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia.
Vijayaraghavan S; Maetzler W; Reimold M; Lithner CU; Liepelt-Scarfone I; Berg D; Darreh-Shori T
Alzheimers Dement; 2014 Sep; 10(5):530-540.e1. PubMed ID: 23978325
[TBL] [Abstract][Full Text] [Related]
3. Association of plasma and cortical amyloid beta is modulated by APOE ε4 status.
Swaminathan S; Risacher SL; Yoder KK; West JD; Shen L; Kim S; Inlow M; Foroud T; Jagust WJ; Koeppe RA; Mathis CA; Shaw LM; Trojanowski JQ; Soares H; Aisen PS; Petersen RC; Weiner MW; Saykin AJ;
Alzheimers Dement; 2014 Jan; 10(1):e9-e18. PubMed ID: 23541187
[TBL] [Abstract][Full Text] [Related]
4. Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts.
Resnick SM; Bilgel M; Moghekar A; An Y; Cai Q; Wang MC; Thambisetty M; Prince JL; Zhou Y; Soldan A; Wong DF; O'Brien RJ; Ferrucci L; Albert MS
Neurobiol Aging; 2015 Aug; 36(8):2333-9. PubMed ID: 26004017
[TBL] [Abstract][Full Text] [Related]
5. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
[TBL] [Abstract][Full Text] [Related]
6. CSF levels of Aβ1-38/Aβ1-40/Aβ1-42 and (11)C PiB-PET studies in three clinical variants of primary progressive aphasia and Alzheimer's disease.
Ikeda M; Tashiro Y; Takai E; Kurose S; Fugami N; Tsuda K; Arisaka Y; Kodaira S; Fujita Y; Makioka K; Mizuno Y; Shimada H; Harigaya Y; Takatama M; Amari M; Yamazaki T; Yamaguchi H; Higuchi T; Okamoto K; Tsushima Y; Ikeda Y
Amyloid; 2014 Dec; 21(4):238-45. PubMed ID: 25139672
[TBL] [Abstract][Full Text] [Related]
7. Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh Compound B units of brain Aβ amyloid.
Weigand SD; Vemuri P; Wiste HJ; Senjem ML; Pankratz VS; Aisen PS; Weiner MW; Petersen RC; Shaw LM; Trojanowski JQ; Knopman DS; Jack CR;
Alzheimers Dement; 2011 Mar; 7(2):133-41. PubMed ID: 21282074
[TBL] [Abstract][Full Text] [Related]
8. Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers.
Schöll M; Wall A; Thordardottir S; Ferreira D; Bogdanovic N; Långström B; Almkvist O; Graff C; Nordberg A
Neurology; 2012 Jul; 79(3):229-36. PubMed ID: 22700814
[TBL] [Abstract][Full Text] [Related]
9. Relationships between biomarkers in aging and dementia.
Jagust WJ; Landau SM; Shaw LM; Trojanowski JQ; Koeppe RA; Reiman EM; Foster NL; Petersen RC; Weiner MW; Price JC; Mathis CA;
Neurology; 2009 Oct; 73(15):1193-9. PubMed ID: 19822868
[TBL] [Abstract][Full Text] [Related]
10. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition.
Park JC; Han SH; Cho HJ; Byun MS; Yi D; Choe YM; Kang S; Jung ES; Won SJ; Kim EH; Kim YK; Lee DY; Mook-Jung I
Alzheimers Res Ther; 2017 Mar; 9(1):20. PubMed ID: 28330509
[TBL] [Abstract][Full Text] [Related]
11. Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer's disease.
Wang MJ; Yi S; Han JY; Park SY; Jang JW; Chun IK; Kim SE; Lee BS; Kim GJ; Yu JS; Lim K; Kang SM; Park YH; Youn YC; An SSA; Kim S
Alzheimers Res Ther; 2017 Dec; 9(1):98. PubMed ID: 29246249
[TBL] [Abstract][Full Text] [Related]
12. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
13. Pittsburgh compound B-negative dementia: a possibility of misdiagnosis of patients with non-alzheimer disease-type dementia as having AD.
Shimada H; Ataka S; Takeuchi J; Mori H; Wada Y; Watanabe Y; Miki T
J Geriatr Psychiatry Neurol; 2011 Sep; 24(3):123-6. PubMed ID: 21750305
[TBL] [Abstract][Full Text] [Related]
14. Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels.
Babulal GM; Ghoshal N; Head D; Vernon EK; Holtzman DM; Benzinger TLS; Fagan AM; Morris JC; Roe CM
Am J Geriatr Psychiatry; 2016 Nov; 24(11):1095-1104. PubMed ID: 27426238
[TBL] [Abstract][Full Text] [Related]
15. Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study.
Leuzy A; Chiotis K; Hasselbalch SG; Rinne JO; de Mendonça A; Otto M; Lleó A; Castelo-Branco M; Santana I; Johansson J; Anderl-Straub S; von Arnim CA; Beer A; Blesa R; Fortea J; Herukka SK; Portelius E; Pannee J; Zetterberg H; Blennow K; Nordberg A
Brain; 2016 Sep; 139(Pt 9):2540-53. PubMed ID: 27401520
[TBL] [Abstract][Full Text] [Related]
16. Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of PiB-PET images and correlation with CSF concentrations of Aβ species.
Oliveira F; Leuzy A; Castelhano J; Chiotis K; Hasselbalch SG; Rinne J; Mendonça A; Otto M; Lleó A; Santana I; Johansson J; Anderl-Straub S; Arnim C; Beer A; Blesa R; Fortea J; Sanna-Kaisa H; Portelius E; Pannee J; Zetterberg H; Blennow K; Moreira AP; Abrunhosa A; Nordberg A; Castelo-Branco M
Neuroimage Clin; 2018; 20():603-610. PubMed ID: 30186764
[TBL] [Abstract][Full Text] [Related]
17. Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease.
Villeneuve S; Vogel JW; Gonneaud J; Pichet Binette A; Rosa-Neto P; Gauthier S; Bateman RJ; Fagan AM; Morris JC; Benzinger TLS; Johnson SC; Breitner JCS; Poirier J;
JAMA Neurol; 2018 May; 75(5):608-619. PubMed ID: 29482212
[TBL] [Abstract][Full Text] [Related]
18. Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging.
Gupta VB; Laws SM; Villemagne VL; Ames D; Bush AI; Ellis KA; Lui JK; Masters C; Rowe CC; Szoeke C; Taddei K; Martins RN;
Neurology; 2011 Mar; 76(12):1091-8. PubMed ID: 21422459
[TBL] [Abstract][Full Text] [Related]
19. High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters.
Forsberg A; Almkvist O; Engler H; Wall A; Långström B; Nordberg A
Curr Alzheimer Res; 2010 Feb; 7(1):56-66. PubMed ID: 20205671
[TBL] [Abstract][Full Text] [Related]
20. Urine AD7c-NTP Predicts Amyloid Deposition and Symptom of Agitation in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
Zhang N; Zhang L; Li Y; Gordon ML; Cai L; Wang Y; Xing M; Cheng Y
J Alzheimers Dis; 2017; 60(1):87-95. PubMed ID: 28777752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
